Clinical Trial Update: Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) [Phase 3]

View source ↗

Summary

Phase 3 trial results for nirogacestat in adults with desmoid-type fibromatosis have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid-type Fibromatosis

Drugs mentioned

• Nirogacestat (nirogacestat)

Snippet

Sponsor: SpringWorks Therapeutics, Inc. | Conditions: Desmoid Tumor, Aggressive Fibromatosis | Phase 3 | Status: COMPLETED | Results posted: 2024-06-12